{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:50:14Z","timestamp":1791366614685,"version":"4.3.1"},"reference-count":42,"publisher":"Georg Thieme Verlag KG","issue":"09","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Neuropsiquiatr"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Emerging evidence highlights a bidirectional interaction between the gut microbiota (GM) and the neuromuscular system, suggesting that microbial composition and metabolic activity may play a pivotal role in the pathophysiology of several neuromuscular diseases (NMDs). This comprehensive review synthesizes current evidence on GM alterations across a broad spectrum of NMDs, emphasizing their potential implications for disease mechanisms and management. Gut microbial shifts have been consistently associated with immune dysregulation, systemic inflammation, and metabolic disturbances that may contribute to neuromuscular dysfunction. Beyond their pathogenetic relevance, these alterations hold diagnostic and therapeutic promise. Probiotic supplementation, dietary modulation, and other microbiota-targeted strategies have shown preliminary benefits in alleviating symptoms and improving metabolic balance in selected NMDs, although existing studies remain limited and heterogeneous. This review offers an integrative perspective, positioning the GM not only as a potential biomarker for diagnosis and disease monitoring but also as a novel therapeutic target. A deeper understanding of the gut\u2013muscle\u2013nerve axis could pave the way for more personalized and mechanism-based approaches in neuromuscular medicine, particularly for disorders where disease-modifying treatments are still lacking. Further well-designed, longitudinal, and mechanistic studies are warranted to elucidate causal relationships and translate microbiome research into clinical application.<\/jats:p>","DOI":"10.1055\/s-0046-1829037","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:39:45Z","timestamp":1791362385000},"page":"001-013","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbiota and neuromuscular disorders: a comprehensive review"],"prefix":"10.1055","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3027-7863","authenticated-orcid":false,"given":"Christian","family":"Messina","sequence":"additional","affiliation":[{"name":"Azienda Sanitaria Provinciale Catania, Catania, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1225875","DOI":"10.3389\/fnins.2023.1225875","article-title":"The gut microbiota-brain axis in neurological disorder","volume":"17","author":"H Ullah","year":"2023","journal-title":"Front Neurosci"},{"issue":"01","key":"ref2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/nu17010081","article-title":"The Relationship Between Gut Microbiota, Muscle Mass and Physical Function in Older Individuals: A Systematic Review","volume":"17","author":"D J Barry","year":"2024","journal-title":"Nutrients"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1065365","DOI":"10.3389\/fmed.2022.1065365","article-title":"Gut-muscle crosstalk. A perspective on influence of microbes on muscle function","volume":"9","author":"W Chew","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"04","key":"ref4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00223-017-0345-5","article-title":"Gut Microbiota Contribute to Age-Related Changes in Skeletal Muscle Size, Composition, and Function: Biological Basis for a Gut-Muscle Axis","volume":"102","author":"G J Grosicki","year":"2018","journal-title":"Calcif Tissue Int"},{"issue":"01","key":"ref5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/neurolint15010026","article-title":"The Role of Human Microbiota in Myasthenia Gravis: A Narrative Review","volume":"15","author":"G Schir\u00f2","year":"2023","journal-title":"Neurol Int"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"109173","DOI":"10.1016\/j.clim.2022.109173","article-title":"Gut microbiota and metabolites in myasthenia gravis: Early diagnostic biomarkers and therapeutic strategies","volume":"245","author":"Y Kang","year":"2022","journal-title":"Clin Immunol"},{"issue":"01","key":"ref7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13578-023-01163-8","article-title":"Causal relationship between gut microbiota and myasthenia gravis: a bidirectional mendelian randomization study","volume":"13","author":"T Su","year":"2023","journal-title":"Cell Biosci"},{"issue":"08","key":"ref8","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3390\/nu14081647","article-title":"Exploring the Gut Microbiome in Myasthenia Gravis","volume":"14","author":"A Y-K Thye","year":"2022","journal-title":"Nutrients"},{"issue":"18","key":"ref9","doi-asserted-by":"publisher","first-page":"1901441","DOI":"10.1002\/advs.201901441","article-title":"Perturbed Microbial Ecology in Myasthenia Gravis: Evidence from the Gut Microbiome and Fecal Metabolome","volume":"6","author":"P Zheng","year":"2019","journal-title":"Adv Sci (Weinh)"},{"issue":"02","key":"ref10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ajpath.2023.10.010","article-title":"Insight into the Role of Gut Microbiota in Duchenne Muscular Dystrophy: An Age-Related Study in Mdx Mice","volume":"194","author":"M Jollet","year":"2024","journal-title":"Am J Pathol"},{"issue":"20","key":"ref11","doi-asserted-by":"publisher","first-page":"11310","DOI":"10.3390\/ijms252011310","article-title":"The Gut Microbiota Involvement in the Panorama of Muscular Dystrophy Pathogenesis","volume":"25","author":"C Russo","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"11","key":"ref12","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.3390\/ijms25115589","article-title":"Exploring the Gut Microbiota-Muscle Axis in Duchenne Muscular Dystrophy","volume":"25","author":"D Mostosi","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"09","key":"ref13","doi-asserted-by":"publisher","first-page":"11799","DOI":"10.1007\/s12035-025-04974-7","article-title":"Exploratory Analysis of Gut Microbiota Profile in Duchenne Muscular Dystrophy (DMD) Patients with Intellectual Disability","volume":"62","author":"C Panicucci","year":"2025","journal-title":"Mol Neurobiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/j.csbj.2024.05.009","article-title":"Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1","volume":"23","author":"M Mahdavi","year":"2024","journal-title":"Comput Struct Biotechnol J"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.csbj.2025.02.016","article-title":"Influence of CTG repeats from the human DM1 locus on murine gut microbiota","volume":"27","author":"M Mahdavi","year":"2025","journal-title":"Comput Struct Biotechnol J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"104441.543","DOI":"10.1016\/j.nmd.2024.07.552","article-title":"468P Exploring gut microbiome alteration in children with myotonic dystrophy type 1: a pilot study","volume":"43","author":"A van Uden","year":"2024","journal-title":"Neuromuscul Disord"},{"issue":"06","key":"ref17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11940-024-00790-x","article-title":"Updates on Facioscapulohumeral Muscular Dystrophy (FSHD)","volume":"26","author":"A XY Chin","year":"2024","journal-title":"Curr Treat Options Neurol"},{"issue":"01","key":"ref18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/cjn.2025.10388","article-title":"Gut Microbiota and Short-Chain Fatty Acid Profiles in Facioscapulohumeral Dystrophy: Associations with Epigenetic Alterations","volume":"53","author":"C Hangul","year":"2026","journal-title":"Can J Neurol Sci"},{"issue":"01","key":"ref19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1017\/cjn.2025.10389","article-title":"Reviewer Comment on Hangul et al. \u201cGut Microbiota and Short-Chain Fatty Acid Profiles in Facioscapulohumeral Dystrophy: Associations with Epigenetic Alterations\u201d","volume":"53","author":"F Y\u00f6r\u00fck","year":"2025","journal-title":"Can J Neurol Sci"},{"issue":"10","key":"ref20","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"P Masrori","year":"2020","journal-title":"Eur J Neurol"},{"issue":"18","key":"ref21","doi-asserted-by":"publisher","first-page":"9966","DOI":"10.3390\/ijms25189966","article-title":"Understanding Amyotrophic Lateral Sclerosis: Pathophysiology, Diagnosis, and Therapeutic Advances","volume":"25","author":"R E Rizea","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"01","key":"ref22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/sclerosis3010008","article-title":"Microbial Influences on Amyotrophic Lateral Sclerosis: The Gut\u2013Brain Axis and Therapeutic Potential of Microbiota Modulation","volume":"3","author":"V Ayala","year":"2025","journal-title":"Sclerosis"},{"issue":"04","key":"ref23","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/joim.13336","article-title":"Gut microbiome and amyotrophic lateral sclerosis: A systematic review of current evidence","volume":"290","author":"J Sun","year":"2021","journal-title":"J Intern Med"},{"issue":"01","key":"ref24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12017-025-08870-0","article-title":"Dysbiosis and Neurodegeneration in ALS: Unraveling the Gut-Brain Axis","volume":"27","author":"V K Sharma","year":"2025","journal-title":"Neuromolecular Med"},{"issue":"03","key":"ref25","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.3390\/ijms25031871","article-title":"Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS","volume":"25","author":"A Lee","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"06","key":"ref26","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1007\/s43440-025-00800-y","article-title":"Dietary modulation of the gut microbiome as a supportive strategy in the treatment of amyotrophic lateral sclerosis \u2013 a narrative review","volume":"77","author":"A Kiecka","year":"2025","journal-title":"Pharmacol Rep"},{"issue":"01","key":"ref27","doi-asserted-by":"publisher","first-page":"2406379","DOI":"10.1080\/19490976.2024.2406379","article-title":"Akkermansia in the gastrointestinal tract as a modifier of human health","volume":"16","author":"M E Panzetta","year":"2024","journal-title":"Gut Microbes"},{"issue":"06","key":"ref28","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/imj.15358","article-title":"Idiopathic inflammatory myopathies: a review","volume":"51","author":"C Ashton","year":"2021","journal-title":"Intern Med J"},{"issue":"05","key":"ref29","doi-asserted-by":"publisher","first-page":"100479","DOI":"10.1016\/j.xinn.2023.100479","article-title":"Gut microbiota in muscular atrophy development, progression, and treatment: New therapeutic targets and opportunities","volume":"4","author":"S Chen","year":"2023","journal-title":"Innovation (Camb)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"757099","DOI":"10.3389\/fcimb.2022.757099","article-title":"Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study","volume":"12","author":"Y Zhufeng","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"01","key":"ref31","doi-asserted-by":"publisher","first-page":"16158","DOI":"10.1038\/s41598-024-60225-0","article-title":"Familial clustering of dysbiotic oral and fecal microbiomes in juvenile dermatomyositis","volume":"14","author":"S T Koester","year":"2024","journal-title":"Sci Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1243512","DOI":"10.3389\/fcimb.2023.1243512","article-title":"Gut microbiota dysbiosis characterized by abnormal elevation of Lactobacillus in patients with immune-mediated necrotizing myopathy","volume":"13","author":"X Liang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1409497","DOI":"10.3389\/fmicb.2024.1409497","article-title":"Genetically predicted the causal relationship between gut microbiota and the risk of polymyositis\/dermatomyositis: a Mendelian randomization analysis","volume":"15","author":"Y Niu","year":"2024","journal-title":"Front Microbiol"},{"issue":"01","key":"ref34","doi-asserted-by":"publisher","first-page":"e200374","DOI":"10.1212\/CPJ.0000000000200374","article-title":"Spinal Muscular Atrophy Update in Best Practices: Recommendations for Treatment Considerations","volume":"15","author":"M K Schroth","year":"2025","journal-title":"Neurol Clin Pract"},{"issue":"03","key":"ref35","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s40120-023-00477-6","article-title":"The Alterations of Gut Microbiome and Lipid Metabolism in Patients with Spinal Muscular Atrophy","volume":"12","author":"Y Feng","year":"2023","journal-title":"Neurol Ther"},{"issue":"25","key":"ref36","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.3748\/wjg.v29.i25.3932","article-title":"Glycogen storage diseases: An update","volume":"29","author":"E G\u00fcm\u00fc\u015f","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"04","key":"ref37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.21037\/tp-22-293","article-title":"Altered gut microbiota and microbial metabolism in children with hepatic glycogen storage disease: a case-control study","volume":"12","author":"Y Wang","year":"2023","journal-title":"Transl Pediatr"},{"issue":"04","key":"ref38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/metabo10040133","article-title":"Proteobacteria Overgrowth and Butyrate-Producing Taxa Depletion in the Gut Microbiota of Glycogen Storage Disease Type 1 Patients","volume":"10","author":"C Ceccarani","year":"2020","journal-title":"Metabolites"},{"issue":"05","key":"ref39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41430-024-01412-0","article-title":"Intestinal microbiota composition of children with glycogen storage Type I patients","volume":"78","author":"S Gokalp","year":"2024","journal-title":"Eur J Clin Nutr"},{"issue":"01","key":"ref40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12602-017-9372-9","article-title":"Effect of VSL#3 Probiotic in a Patient with Glycogen Storage Disease Type Ia and Irritable Bowel Disease-like Disease","volume":"11","author":"M Carnero-Gregorio","year":"2019","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1575464","DOI":"10.3389\/fimmu.2025.1575464","article-title":"A pathophysiological and mechanistic review of chronic inflammatory demyelinating polyradiculoneuropathy therapy","volume":"16","author":"M Caballero-\u00c1vila","year":"2025","journal-title":"Front Immunol"},{"issue":"01","key":"ref42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13578-023-00956-1","article-title":"Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"13","author":"J Fu","year":"2023","journal-title":"Cell Biosci"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0046-1829037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:56:33Z","timestamp":1791363393000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0046-1829037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2026,6,25]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["s00461829037"],"URL":"https:\/\/doi.org\/10.1055\/s-0046-1829037","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0004-282X","1678-4227"],"issn-type":[{"value":"0004-282X","type":"print"},{"value":"1678-4227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}